AngioDynamics Foresees New Laser Sales Opportunities With Sotradecol Drug
This article was originally published in The Gray Sheet
Executive Summary
AngioDynamics expects to expand into hitherto untargeted markets with the help of its newly licensed Sotradecol drug for the treatment of small, uncomplicated varicose veins